All Stories

Featured Stories

Evaluating Innovations in Middle Molecule Clearance

Evaluating Innovations in Middle Molecule Clearance

“The secret of the care of the patient is in caring for the patient.”¹ None of us would ever choose to have kidney failure. And that is exactly why innovations that help patients feel better and live healthier are critical to our work serving the kidney community.   Middle molecule clearance is emerging as a meaningful […]
READ MORE >
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems

Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems

For U.S. healthcare systems, clinical and financial stability can be achieved when we look beyond treatment options for individual disease states and instead take a more holistic approach that also addresses the pathological mechanisms that extend across multiple disease states. The American Heart Association definition of the cardiovascular-kidney-metabolic syndrome (CKM syndrome), a systemic overlap of […]
READ MORE >
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression

SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression

For years, kidney care has primarily focused on managing kidney failure. Now, new data is empowering a crucial clinical focus: preserving kidney function before kidney disease advances. A recent study published in JAMA Internal Medicine provides a compelling signal for care providers: When it comes to slowing chronic kidney disease (CKD) progression for people with […]
READ MORE >

This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.